216 related articles for article (PubMed ID: 14987403)
1. Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis.
Anzola M; Burgos JJ
Expert Rev Mol Med; 2003 Nov; 5(28):1-16. PubMed ID: 14987403
[TBL] [Abstract][Full Text] [Related]
2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
3. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and the underlying mechanisms.
Oyagbemi AA; Azeez OI; Saba AB
Afr Health Sci; 2010 Mar; 10(1):93-8. PubMed ID: 20811532
[TBL] [Abstract][Full Text] [Related]
6. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
7. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.
Anzola M
J Viral Hepat; 2004 Sep; 11(5):383-93. PubMed ID: 15357643
[TBL] [Abstract][Full Text] [Related]
11. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
12. Genes and viruses in hepatobiliary neoplasia.
Reeves ME; DeMatteo RP
Semin Surg Oncol; 2000; 19(2):84-93. PubMed ID: 11126384
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
14. [The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis].
Feng D; Zheng H; Yan Y
Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):278-80. PubMed ID: 10923485
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
16. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.
Sedeno-Monge V; Vallejo-Ruiz V; Sosa-Jurado F; Santos-Lopez G
J Biosci; 2017 Sep; 42(3):509-521. PubMed ID: 29358564
[TBL] [Abstract][Full Text] [Related]
18. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis.
Poole MI; Sorribes I; Jain HV
Math Biosci; 2018 Dec; 306():186-196. PubMed ID: 30312632
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core protein overcomes H2O2-induced apoptosis by downregulating p14 expression via DNA methylation.
Seo YL; Heo S; Jang KL
J Gen Virol; 2015 Apr; 96(Pt 4):822-832. PubMed ID: 25535325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]